Literature DB >> 2991474

Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy.

J M Schröder, M Hoheneck, J Weis, H Deist.   

Abstract

A case is reported of ethylene oxide polyneuropathy after 5 months of exposure. There was symmetrical distal weakness of both lower extremities and transitory reduced nerve conduction velocities with increased latencies. Sural nerve biopsy revealed nerve fibre degeneration of the Wallerian type, associated with reduction of axonal cross-sectional areas and some degree of nerve fibre regeneration that could be confirmed morphometrically. In addition, there was conspicuous paranodal vesicular disintegration of individual myelin lamellae. Unusual cisternae with introverted hemidesmosomes were noted in endoneurial fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991474     DOI: 10.1007/bf00313906

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Hexachlorophene myelinopathy in premature infants.

Authors:  H Powell; O Swarner; L Gluck; P Lampert
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

2.  The normal sural nerve in man. II. Changes in the axons and Schwann cells due to ageing.

Authors:  J Ochoa; W G Mair
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

3.  The normal sural nerve in man. I. Ultrastructure and numbers of fibres and cells.

Authors:  J Ochoa; W G Mair
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

4.  [Light and electron microscopic studies of late stages of thalidomide polyneuropathy].

Authors:  W Krücke; H H von Hartrott; J M Schröder; E Thomas; E Gibbels; W Scheid
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1971-01

5.  Effect of serum hyperosmolality on morphometry of healthy human sural nerve.

Authors:  P J Dyck; P A Low; M F Sparks; L A Hexum; J L Karnes
Journal:  J Neuropathol Exp Neurol       Date:  1980-05       Impact factor: 3.685

6.  The axonal pathology in chronic IDPN intoxication.

Authors:  A W Clark; J W Griffin; D L Price
Journal:  J Neuropathol Exp Neurol       Date:  1980-01       Impact factor: 3.685

7.  Rapid alterations of the axon membrane in antibody-mediated demyelination.

Authors:  K Saida; T Saida; H Kayama; H Nishitani
Journal:  Ann Neurol       Date:  1984-06       Impact factor: 10.422

8.  3,3'-Iminodipropionitrile induced centrifugal segmental demyelination and onion bulb formation.

Authors:  M Shimono; K Izumi; V Kuroiwa
Journal:  J Neuropathol Exp Neurol       Date:  1978 Jul-Aug       Impact factor: 3.685

9.  Ethylene oxide-induced polyneuropathy. A clinical and electrophysiologic study.

Authors:  P F Finelli; T F Morgan; I Yaar; C V Granger
Journal:  Arch Neurol       Date:  1983-07

10.  Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats.

Authors:  H Dunkelberg
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

View more
  10 in total

Review 1.  [Inflammatory and other myopathies and skeletal muscle vasculitis: the role of muscle and nerve biopsy].

Authors:  J Weis; K Nolte
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

2.  Inhibition of creatine kinase activity by ethylene oxide.

Authors:  M Matsuoka; H Igisu; N Inoue; H Hori; I Tanaka
Journal:  Br J Ind Med       Date:  1990-01

3.  Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy.

Authors:  Peter Reilich; Nicolai Schramm; Benedikt Schoser; Peter Schneiderat; Nicola Strigl-Pill; Josef Müller-Höcker; Wolfram Kress; Andreas Ferbert; Sabine Rudnik-Schöneborn; Johannes Noth; Hanns Lochmüller; Joachim Weis; Maggie C Walter
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

4.  The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.

Authors:  Peter Reilich; Rita Horvath; Sabine Krause; Nicolai Schramm; Doug M Turnbull; Michael Trenell; Kieren G Hollingsworth; Grainne S Gorman; Volkmar H Hans; Jens Reimann; Andrée MacMillan; Lesley Turner; Annette Schollen; Gregor Witte; Birgit Czermin; Elke Holinski-Feder; Maggie C Walter; Benedikt Schoser; Hanns Lochmüller
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

5.  Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.

Authors:  Janos Groh; Joachim Weis; Hanna Zieger; E Richard Stanley; Heike Heuer; Rudolf Martini
Journal:  Brain       Date:  2011-11-16       Impact factor: 13.501

6.  HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts.

Authors:  C Sommer; J M Schröder
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Authors:  Maike F Dohrn; Christoph Röcken; Jan L De Bleecker; Jean-Jacques Martin; Matthias Vorgerd; Peter Y Van den Bergh; Andreas Ferbert; Katrin Hinderhofer; J Michael Schröder; Joachim Weis; Jörg B Schulz; Kristl G Claeys
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

8.  A de novo gain-of-function mutation in SCN11A causes loss of pain perception.

Authors:  Enrico Leipold; Lutz Liebmann; G Christoph Korenke; Theresa Heinrich; Sebastian Giesselmann; Jonathan Baets; Matthias Ebbinghaus; R Oliver Goral; Tommy Stödberg; J Christopher Hennings; Markus Bergmann; Janine Altmüller; Holger Thiele; Andrea Wetzel; Peter Nürnberg; Vincent Timmerman; Peter De Jonghe; Robert Blum; Hans-Georg Schaible; Joachim Weis; Stefan H Heinemann; Christian A Hübner; Ingo Kurth
Journal:  Nat Genet       Date:  2013-09-15       Impact factor: 38.330

Review 9.  Processing of nerve biopsies: a practical guide for neuropathologists.

Authors:  Joachim Weis; Sebastian Brandner; Martin Lammens; Claudia Sommer; Jean-Michel Vallat
Journal:  Clin Neuropathol       Date:  2012 Jan-Feb       Impact factor: 1.368

10.  Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances.

Authors:  J T Vollrath; A Sechi; A Dreser; I Katona; D Wiemuth; J Vervoorts; M Dohmen; A Chandrasekar; J Prause; E Brauers; C M Jesse; J Weis; A Goswami
Journal:  Cell Death Dis       Date:  2014-06-12       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.